ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 482

The Association of Short-Term Ultraviolet Radiation Exposure and Calcinosis in Juvenile Dermatomyositis in the Childhood Arthritis & Rheumatology Research Alliance Registry

Jessica Neely1, Craig S. Long2, Hugh Sturrock3 and Susan Kim4, 1Pediatric Rheumatology, University of California, San Francisco, San Francisco, CA, 2National Oceanic and Atmospheric Administration (NOAA)/Climate Prediction Center, College Park, MD, 3Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 4Pediatric Rheumatology, University of California, San francisco School of Medicine, San Francisco, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: calcinosis, Environmental factors, juvenile dermatomyositis and race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: JDM is an autoimmune systemic vasculopathy characterized by myositis and skin rash.  Some myositis specific antibodies (MSAs) are associated with clinical manifestations in JDM, including extensive photosensitive rash and a chronic disease course. Prior research demonstrates a link between UV radiation (UVR) and certain MSAs. However, it is unclear if UVR worsens disease severity in JDM. We investigated the association between UVR and development of calcinosis, which we used as a proxy for severe disease. Understanding the role of UVR in disease severity may help clinicians develop interventions to limit UV exposure and poor outcomes in JDM.

Methods: This was a cross-sectional study of JDM subjects in the U.S. multi-center Childhood Arthritis & Rheumatology Research Alliance (CARRA) registry enrolled from 2010-15. We excluded subjects missing date of symptom onset or zip code. Mean UV index (UVI) in the calendar month prior to symptom onset in each subject’s zip code was calculated from daily satellite solar noon measurements. The primary outcome was history of calcinosis. Chi-squared and Kruskal-Wallis tests were used to compare subject characteristics stratified by UV quartiles. Multivariate logistic regression was used with adjustment for sex, race, age, interval to diagnosis, disease duration, and latitude. Race was dichotomized as black or non-black. Interaction between race and UVI was evaluated.

Results: Among subjects (n=522),11% identified as black and 89% as non-black, of which 79% identified as white. Overall, mean UVI was 4.9 (±2.6) and 11% had calcinosis. Stratified by UV quartiles, clinical and demographic characteristics were similar. In a multi-variate analyses, there was no significant relationship between mean UVI and calcinosis (see Table 1 for OR’s). Black race was associated with a 3-fold greater odds of calcinosis. However, when accounting for a statistically significant interaction between race and UVI, black subjects were less likely to develop calcinosis at the mean UVI. At higher UVI levels, the odds of calcinosis steadily increased in the non-black subjects. Additional statistically significant risk factors for calcinosis in our model included male sex, older age at disease onset, longer disease duration, and delay in diagnosis.

Conclusion:  In the CARRA JDM registry, we found that black subjects living in areas with lower UVI, had a 3-fold greater odds of calcinosis compared to non-black subjects. However, non-black subjects living in areas with moderate to high UVI, had increased risk of calcinosis beyond those of black subjects suggesting that lighter skinned individuals with JDM may be more susceptible to UVR and subsequent development of calcinosis. Our data suggests UVR is an important factor associated with calcinosis but also highlights the complex interplay between genes and environment present in autoimmune conditions like JDM.

Table 1: Multivariate logistic regression model of mean UVI as a predictor of Calcinosis

Predictor

Unadjusted OR

95% CI

p-value

Adjusted OR

95% CI

p-value

Female sex

0.62

0.34-1.14

0.11

0.48

0.25 – 0.95

0.03*

Age at disease onset (per year)

1.01

0.94-1.09

0.71

1.10

1.01 – 1.20

0.03*

Disease duration (per year)

1.23

1.13-1.33

<0.001*

1.30

1.18 – 1.44

<0.001*

Diagnosis interval (per month)

1.03

1.01-1.05

0.005*

1.04

1.01 – 1.06

<0.001*

Mean UVI

0.94

0.84-1.05

0.25

1.03

0.89 – 1.19

0.66

Black race

3.22

1.54-6.41

0.001*

3.35

1.22 – 8.17

0.01*

Mean UVI*Black race

0.69

0.48-0.95

0.03*

0.67

0.45 – 0.94

0.02*

Mean latitude

1.00

0.94-1.07

0.91

1.00

0.92 – 1.09

0.99

*indicates p-value <0.05. Model adjusted for sex, age, disease duration, diagnosis interval, race and latitude.


Disclosure: J. Neely, None; C. S. Long, None; H. Sturrock, None; S. Kim, None.

To cite this abstract in AMA style:

Neely J, Long CS, Sturrock H, Kim S. The Association of Short-Term Ultraviolet Radiation Exposure and Calcinosis in Juvenile Dermatomyositis in the Childhood Arthritis & Rheumatology Research Alliance Registry [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-association-of-short-term-ultraviolet-radiation-exposure-and-calcinosis-in-juvenile-dermatomyositis-in-the-childhood-arthritis-rheumatology-research-alliance-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-short-term-ultraviolet-radiation-exposure-and-calcinosis-in-juvenile-dermatomyositis-in-the-childhood-arthritis-rheumatology-research-alliance-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology